News and Media
;
Largest study of its kind informs treatment of breast cancer in men
Commonly used recurrence risk tests found to be useful for male patients Breast cancer is usually thought of as a disease that affects women, but many are not aware that men can develop breast cancer as well. Two-hundred and forty men in Canada were diagnosed with the disease in 2020 and it is estimated that […]
Read the story
Oct 08, 2021
Study puts spotlight on FDA’s accelerated approval of cancer drugs
Oct 04, 2021
New AI tool enables analysis of millions of cells within minutes
Sep 07, 2021
Clinical trial breaks new ground on using immunotherapy for more cancer types
Aug 17, 2021
Researchers uncover evolutionary forces at play in the aging of the blood system and identify people at increased risk of blood cancer
Jul 13, 2021
Microscopes and molecules: New OICR Investigator Dr. Rola Saleeb brings integrated approach to cancer pathology
Jul 06, 2021
Learning how to fly blind
Recent Videos
Media Contact
Resources
OICR Brand Guidelines
Jul 28, 2021
Download the OICR brand guidelines.
News Releases
Aug 17, 2021
Researchers uncover evolutionary forces at play in the aging of the blood system and identify people at increased risk of blood cancer
Feb 04, 2021
Clinical trial: Using MRI for prostate cancer diagnosis equals or beats current standard
Jun 25, 2020
CanPath Awarded $2.1 million CIHR Grant for SUPPORT-Canada COVID-19 Initiative
@OICR_News on Twitter
Cancer research news roundup for the week of October 18 - 22: http://ow.ly/gITL50GwsNJ
#cancerresearch #cancernews
Dr. Pieter Cullis will speak about his lipid nanoparticle discoveries in the context of gene therapies for rare diseases, #COVID19 mRNA vaccines, and personalized #cancer therapeutics as the Dr. Mark Ernsting Drug Discovery Memorial Lecturer. https://twitter.com/OICR_news/status/1450517377737756681
On November 5, join OICR and @chemuoft for The Dr. Mark Ernsting Drug Discovery Memorial Lecture. This year's lecture will be delivered by Dr. Pieter Cullis, Professor, @UBCbiochemistry. Registration: http://ow.ly/ovcE50Gu4aY
Join the CVPD @UofT_dlsph on October 25th 12:30-1:30PM EDT, for a webinar on COVID-19 Vaccine Effectiveness and Safety in Canada: Where are we now? feat. @DrJeffKwong, Dr. Philip Awadalla, and Dr. Natalia Abraham. RSVP here: https://buff.ly/2Z2aM15 @UofT @OICR_news @AwadallaLab
Study by @oncology_bg and collaborators puts spotlight on FDA’s accelerated approval of cancer drugs: https://oicr.on.ca/study-puts-spotlight-on-fdas-accelerated-approval-of-cancer-drugs/
On November 5, join OICR and @chemuoft for The Dr. Mark Ernsting Drug Discovery Memorial Lecture. This year's lecture will be delivered by Dr. Pieter Cullis, Professor, @UBCbiochemistry. Registration: http://ow.ly/ovcE50Gu4aY
Now for the good side of viruses🦠...
#Cancer symposium event from @OICR_news and @JLABS on Nov. 17 at 10am ET.
"Going viral: Examining advancements in oncolytic viral therapies and their future"
OICR-JLABS cancer symposium series - November 17 - Ontario Institute for Cancer Research
November 17 from 10-11:30 a.m. ET Oncolytic (cancer-killing) viruses are one of the most promising forms of immunoth...
bit.ly
Join OICR and @JLABS on Nov. 18 for "Going viral: Examining advancements in oncolytic viral therapies and their future". This symposium features leading experts from across this exciting field, including keynote speaker Dr. Robert Coffin of @Replimune.
https://oicr.on.ca/oicr-jlabs-cancer-symposium-series-november-17/
Cancer research news roundup for the week of October 4 - 8, 2021: http://ow.ly/Apib50GoFSa
#cancerresearch #cancernews
"Astir", a new #AI tool developed by @kieranrcampbell and collaborators, enables cell type assignment of millions of cells within minutes using highly multiplexed imaging data https://oicr.on.ca/new-ai-tool-enables-analysis-of-millions-of-cells-within-minutes/ @hartjackson #MachineLearning
We are pleased to share the OICR 2020-2021 Impact Report. Take a look at how OICR continued vital cancer research during the pandemic while making significant scientific contributions to the fight against COVID-19.
The 2020-2021 OICR Impact Report
How we're maximizing the health and economic benefits of cancer research for all Ontarians
ow.ly
Looking Ahead
Receive the latest news, event invites, funding opportunities and more from the Ontario Institute for Cancer Research.